{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:17:38Z","timestamp":1783397858341,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101186","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:06:20Z","timestamp":1778889980000},"page":"101186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prostate cancer radiotherapy in kidney transplant candidates: a planning framework for defining and optimizing transplant-specific organs at risk"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2871-5476","authenticated-orcid":false,"given":"Anna","family":"Gueiderikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9151-3463","authenticated-orcid":false,"given":"Adrien","family":"Panis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1304-3685","authenticated-orcid":false,"given":"Damien","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8641-862X","authenticated-orcid":false,"given":"Yannis","family":"Meraouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bessede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-2938","authenticated-orcid":false,"given":"Charles","family":"Dariane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8232-0056","authenticated-orcid":false,"given":"Philippe","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ctro.2026.101186_b0005","article-title":"Impact of newly diagnosed prostate cancer at time of evaluation for renal transplantation","volume":"37","author":"Poinard","year":"2023","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.ctro.2026.101186_b0010","doi-asserted-by":"crossref","unstructured":"Culty T, Goujon A, Defortescu G, Bessede T, Kleinclauss F, Boissier R, et al. Recommandations fran\u00e7aises du Comit\u00e9 de transplantation de l\u2019Association fran\u00e7aise d\u2019urologie (CTAFU) : cancer de la prostate localis\u00e9 chez le patient transplant\u00e9 r\u00e9nal ou en attente de transplantation. Progr\u00e8s en Urologie. 1 janv 2021;31(1):4\u201117. doi:10.1016\/j.purol.2020.04.027.","DOI":"10.1016\/j.purol.2020.04.027"},{"key":"10.1016\/j.ctro.2026.101186_b0015","unstructured":"EAU Guidelines on Renal Transplantation - THE GUIDELINE - Uroweb [Internet]. [cit\u00e9 1 mai 2026]. Disponible sur: https:\/\/uroweb.org\/guidelines\/renal-transplantation\/chapter\/the-guideline."},{"key":"10.1016\/j.ctro.2026.101186_b0020","doi-asserted-by":"crossref","unstructured":"Fran\u00e7ot M, Mesnard B, Kerleau C, Chelghaf I, de Vergie S, Perrouin Verbe MA, et al. Kidney transplantation after pelvic radiotherapy: Increased morbidity? The French Journal of Urology. 1 sept 2024;34(9):102667. doi:10.1016\/j.fjurol.2024.102667.","DOI":"10.1016\/j.fjurol.2024.102667"},{"key":"10.1016\/j.ctro.2026.101186_b0025","doi-asserted-by":"crossref","unstructured":"Mouzin M, Bachaud JM, Kamar N, Gam\u00e9 X, Vaessen C, Rischmann P, et al. Three-Dimensional Conformal Radiotherapy for Localized Prostate Cancer in Kidney Transplant Recipients. Transplantation. 27 nov 2004;78(10):1496. doi:10.1097\/01.TP.0000137933.97259.E7.","DOI":"10.1097\/01.TP.0000137933.97259.E7"},{"key":"10.1016\/j.ctro.2026.101186_b0030","doi-asserted-by":"crossref","unstructured":"Dohm A, Sanchez J, Stotsky-Himelfarb E, Willingham FF, Hoffe S. Strategies to Minimize Late Effects From Pelvic Radiotherapy. Am Soc Clin Oncol Educ Book. juin 2021;(41):158\u201168. doi:10.1200\/EDBK_320999.","DOI":"10.1200\/EDBK_320999"},{"issue":"1","key":"10.1016\/j.ctro.2026.101186_b0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.radonc.2013.08.009","article-title":"Radiation-induced carotid artery atherosclerosis","volume":"110","author":"Gujral","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101186_b0040","doi-asserted-by":"crossref","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br\u00f8nnum D, et al. Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. New England Journal of Medicine. 14 mars 2013;368(11):987\u20119doi:10.1056\/NEJMoa1209825 PubMed PMID: 23484825.","DOI":"10.1056\/NEJMoa1209825"},{"key":"10.1016\/j.ctro.2026.101186_b0045","unstructured":"EAU Guidelines on Renal Transplantation - Uroweb [Internet]. [cit\u00e9 31 oct 2025]. Disponible sur: https:\/\/uroweb.org\/guidelines\/renal-transplantation\/summary-of-changes\/2025."},{"key":"10.1016\/j.ctro.2026.101186_b0050","unstructured":"K\u00fcss, Teinturier, Milliez. Quelques essais de greffe de rein chez l\u2019homme. M\u00e9moires de l\u2019Acad\u00e9mie Nationale de Chirurgie. 1951."},{"issue":"14","key":"10.1016\/j.ctro.2026.101186_b0055","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.3390\/jcm13144188","article-title":"Surgical strategies for renal transplantation: a pictorial essay","volume":"13","author":"Novacescu","year":"2024","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.ctro.2026.101186_b0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.purol.2016.03.005","article-title":"Urological complications after kidney transplantation from extended criteria donors: Ureteroneocystostomy versus pyelo-ureterostomy","volume":"26","author":"Promeyrat","year":"2016","journal-title":"Prog Urol. mai"},{"key":"10.1016\/j.ctro.2026.101186_b0065","unstructured":"Le rapport annuel REIN 2023 - Agence de la biom\u00e9decine [Internet]. [cit\u00e9 30 oct 2025]. Disponible sur: https:\/\/www.agence-biomedecine.fr\/fr\/observatoire-de-la-maladie-renale-chronique\/le-rapport-annuel-rein-2023."},{"key":"10.1016\/j.ctro.2026.101186_b0070","doi-asserted-by":"crossref","unstructured":"de Crevoisier R, Supiot S, Cr\u00e9hange G, Pommier P, Latorzeff I, Chapet O, et al. External radiotherapy for prostatic cancers. Cancer\/Radioth\u00e9rapie. 1 f\u00e9vr 2022;RecoRadTM26(1):329\u201143. doi:10.1016\/j.canrad.2021.11.017.","DOI":"10.1016\/j.canrad.2021.11.017"},{"key":"10.1016\/j.ctro.2026.101186_b0075","unstructured":"ASTRO [Internet]. [cit\u00e9 2 d\u00e9c 2025]. Androgen Deprivation Therapy (ADT) and High Dose Definitive Radiotherapy (RT) +\/- Whole Pelvic RT in Patients with Unfavorable Intermediate or Favorable High-Risk Prostate Cancer: Early Results of a Phase III Randomized Controlled Trial. Disponible sur: https:\/\/amportal.astro.org\/sessions\/ct-01-21645\/androgen-deprivation-therapy-adt-and-high-dose-definitive-radiotherapy-rt-whole-pelvic-rt-in-109480."},{"key":"10.1016\/j.ctro.2026.101186_b0080","doi-asserted-by":"crossref","unstructured":"Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, et al. Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V\u2013STORM): a phase 2, open-label, randomised controlled trial. The Lancet Oncology. 1 juin 2025;26(6):695\u2011706. doi:10.1016\/S1470-2045(25)00197-4 PubMed PMID: 40339593.","DOI":"10.1016\/S1470-2045(25)00197-4"},{"key":"10.1016\/j.ctro.2026.101186_b0085","doi-asserted-by":"crossref","unstructured":"Gueiderikh A, Baude J, Baron D, Schiappa R, Katsahian S, Moreau D, et al. Nodal radiotherapy for prostate adenocarcinoma recurrence: predictive factors for efficacy. Front Oncol. 25 oct 2024;14:1468248. doi:10.3389\/fonc.2024.1468248 PubMed PMID: 39525616; PubMed Central PMCID: PMC11543566.","DOI":"10.3389\/fonc.2024.1468248"},{"key":"10.1016\/j.ctro.2026.101186_b0090","doi-asserted-by":"crossref","unstructured":"As N van, Griffin C, Tree A, Patel J, Ostler P, Voet H van der, et al. Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer. New England Journal of Medicine. 16 oct 2024;391(15):1413\u201125. doi:10.1056\/NEJMoa2403365.","DOI":"10.1056\/NEJMoa2403365"},{"key":"10.1016\/j.ctro.2026.101186_b0095","doi-asserted-by":"crossref","unstructured":"Tree AC, Hinder V, Chan A, Tolan S, Ostler P, Voet H van der, et al. Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial. The Lancet Oncology. 1 juill 2025;26(7):936\u201147. doi:10.1016\/S1470-2045(25)00205-0 PubMed PMID: 40517778.","DOI":"10.1016\/S1470-2045(25)00205-0"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:47:15Z","timestamp":1783396035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":19,"alternative-id":["S2405630826000819"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101186","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer radiotherapy in kidney transplant candidates: a planning framework for defining and optimizing transplant-specific organs at risk","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101186"}}